The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Kiwi, the half yearly isn't due Wednesday. There have been multiple dates that the half yearly has been released. But it is always the last week of September.
There's been 5 of those this week. I don't think I've missed all those RNS Releases. You do know that companies now release an RNS Direct through the RNS Portal. So going by the conspiracy theory they must then go straight into the broker meeting to buy 1 share.
Received a response to a question I asked. This dosent sit right with me. Unless there is an RNS update on the Half Yearly. This is news worthy. It also has a material affect on the Companies SP therefor, shareholders must be informed.
Hi Kris,
Can you confirm if Synairgen are actively recruiting patients for a UK based Pivotal trial? Both in the home environment and in Hospitals.
Can you also offer an update, on how many have been successfully enrolled into the home trial to date?
Kind Regards
...................................................................................
Hi Graham,
Thank you for your email.
As Synairgen is a listed Company, we are unable to disclose additional information outside of what has been communicated to the market.
Synairgen are working on progressing SNG001 as a treatment for COVID-19 and are in discussions with regulatory agencies worldwide to establish on the regulatory route to approval.
We appreciate your continued support.
Kind regards,
Kris
Just checked RNS history and we are due the half yearly within the next week. It's always the last week of September. I imagine that will be a pretty juicy RNS.
Com909. Your comment showd your lack of understanding. If you think any government approves any drug on the basis of a Peer Review, you should probably give up shares. Governments around the world conduct their own evaluation with their own experts in that field. A Peer Review adds nothing to the value of the company it is merely confirmation or dismissal of the claims made.
I'm also the same. The Friday before the 500% I went 100% all in. Still not sold a single share. Anyone that's ever invested in AIM before is well aware its a news driven market. I'm actually surprised we have only just fallen into this holding pattern. I expected it to retreat back to the 140-150's within weeks of the trial announcements. At this moment SNG is valued on nothing more than potential, as soon as we start seeing revenue generating RNS it will be astronomical.
Hold4, Those are other Covid Peer Reviews. The average time is 4 months. People that would normally conduct these are in labs trying to develop treatments. 4 months is an exceptionally quick turn around in comparison to previous times. A peer review has no bearing whatsoever on T/O or Buyouts or license deals. Any Pharma will conduct their own in depth analysis of the raw data. The current SP is nothing more than an opportunity to buy more cheap. It may even be in the 140s by the end of the week if still no news, I for 1 hope it is gives me an opportunity to buy more on my weekly top up.
Other Peer Reviews are currently taking 4 months from the date the Data is made available.
IV Interferon. Its already an approved drug.
That's the average time of other Peer Reviews currently reporting now.
SNG have absolutely no control over Peer Review Timelines. The COPD results were before end of summer. Peer Review is currently around 4 months which would give us a timetable of end October, beginning of Nov.
Anyone else notice that consillium are also the representative of Vecctura.
Could this be UK Gov trying to avoid issues with supply chains with Brexit? Both British companies
183.5 for 50k shares. All in 1 hit
That trial is from 2010
Don't forget Wait Until The Yanks Wake Up
Aerosolised Interferon as a preventative is not covered under SNG patent. It is only when then person has a confirmed Virus. Also if it is sprayed up the nose that is not classed as administered by inhalation.
With the low volume and stagnant SP over the last few days. What's everyone's view to the next step of MM's. I think they will walk the price down before allowing it to recover this afternoon or tomorrow. Remember they only make money from volume. (Corruption & Manipulation aside)
The conversation happened a few days ago on here and no one knew of any platform allowing a short on SNG. I've never looked for it myself as you'd have to be a lunatic.
Clearly you knew what was actually meant. My phone decided to add the word order. The questions still valid, what platform have you used to short?
Parsley2. I'm having trouble accepting your credibility. You can see from my previous posts I'm absolutely aware of what drives this SP. But what I'm having trouble understanding, is how you can have a sell order when this stock is not available on any platform that enables you to short it.